Navigation Links
Vista Partners Initiates Coverage on Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE)
Date:5/20/2008

LOS ANGELES, May 20 /PRNewswire/ -- Vista Partners announced today that it has initiated coverage on Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE). Ross Silver, Director of Research of Vista Partners stated, "Alseres' recombinant-protein-based drug named Cethrin has shown highly encouraging clinical and preclinical data to date. Cethrin would serve a multi-billion dollar market if approved. In addition to Cethrin, Alseres has a molecular imaging program in Phase III clinical trials, a program we believe will likely be partnered within the next 12 months. Alseres is a highly attractive investment at its current valuation." To download a free copy of the report, please visit the Vista Partners website, http://www.vistap.com and click on the download research icon.

About Vista Partners:

Vista Partners provides independent, equity research to institutional and individual investors, with a focus on publicly traded small capitalization companies. With offices in Los Angeles and San Francisco, Vista Partners is one of the fastest growing independently owned equity research firms. Vista Partners professional staff has backgrounds in finance, corporate communications and investment banking. More information is available at http://www.vistap.com.

About Alseres Pharmaceuticals, Inc.:

Alseres Pharmaceuticals, Inc. (ALSE) is engaged in the development of therapeutic and diagnostic products primarily for disorders in the central nervous system (CNS). The Company maintains a world-class intellectual property position in the field of regenerative therapeutics. The Company's energy and focus is reflected in several important initi
'/>"/>

SOURCE Vista Partners
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
2. Vista Partners Initiates Coverage on Raptor Pharmaceuticals Corp.
3. Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. Vista Partners Updates Coverage on Raptor Pharmaceuticals Corp.
5. Boston Scientific Agrees To Sell Fluid Management and Venous Access Businesses to Avista Capital Partners for $425 Million
6. Avista Capital Partners Completes Acquisition of Bristol-Myers Squibb Medical Imaging
7. Accipiter Capital Management Opposes Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc.
8. Accipiter Capital Management Reaffirms Its Opposition to the Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc.
9. Boston Scientific Completes Sale of Fluid Management and Venous Access Businesses to Avista Capital Partners
10. Synvista Therapeutics to Present at the Roth 20th Annual OC Growth Stock Conference
11. Avista Capital Partners Enhances Energy Practice With Appointment of Gerhard Kurz
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 2014 Sugar Manufacturing in ... fluctuations in global supply and demand, which have contributed ... The industry derives a large share of its revenue ... market dynamics, with supply and prices being determined by ... strong Australian dollar for the majority of the past ...
(Date:8/27/2014)... 27, 2014 SCOTT Sports is ... Utah’s first indoor mountain bike and BMX park. SCOTT ... bikes in both adult and youth sizes for the park’s ... a distribution warehouse in Ogden, Utah, recently moved its U.S. ... “We are proud to be a partner with the Wasatch ...
(Date:8/27/2014)... knowledge is power, and a new UCLA study has shown ... making the best decisions about how to treat their prostate ... educated about their disease have a much more difficult time ... negatively impact the quality of their care and their long-term ... for physicians, who can use the findings to target men ...
(Date:8/27/2014)... who eat over 10 portions a week of tomatoes ... prostate cancer, new research suggests. , With 35,000 new ... deaths, prostate cancer is the second most common cancer ... countries, which some experts believe is linked to a ... dietary and lifestyle recommendations reduces risk of prostate cancer, ...
(Date:8/27/2014)... Bedros Keuilian is the founder of the fastest ... fitness boot camp marketing expert in the industry ... thing he knows very well is how to build a ... the fitness business. , In his new, hour-long webinar ... instructional guide on how fitness boot camp owners and personal ...
Breaking Medicine News(10 mins):Health News:Sugar Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Sugar Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Sugar Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:SCOTT Sports to Sponsor Wasatch Indoor Bike Park 2Health News:Men who are uneducated about their prostate cancer have difficulty making good treatment choices 2Health News:Men who are uneducated about their prostate cancer have difficulty making good treatment choices 3Health News:Fighting prostate cancer with a tomato-rich diet 2Health News:Bedros Keuilian Releases New Fitness Boot Camp Marketing Webinar on Building a Personal Brand 2Health News:Bedros Keuilian Releases New Fitness Boot Camp Marketing Webinar on Building a Personal Brand 3
... is to create therapies or simply investigate how organisms ... one of biological science's toughest assignments: keeping their tiny ... have notoriously finicky tastes, and despite a decade of ... the cells will continue dividing indefinitely in culture or ...
... to funding are needed to support the rising numbers ... experts. ,Providing quality health services that ... between Federal and State Governments, and public and private ... their editorial for the Medical Journal of Australia, Ms ...
... study shows that repeated treatments of botulinum toxin type ... in a significant decrease in spasticity, pain frequency ... according to research from a neurologist at Wake Forest ... these outcome measures indicate a better quality of life ...
... is turned on its head yet again, this time on what ... is not cotton or linen , but denim and wool, Swiss ... how people protect their skin. ,Writing in a ... the least effective option. ,The team from the ...
... primary open angle glaucoma (POAG) are not treated medically ... study. ,The study is the first investigation ... data from a nationally representative sample of Medicare patients. ... surgeries among adults aged 65 and older by analyzing ...
... the risk of developing health disorders like cardiovascular disease and ... of developing cancer, a new study says. ,Conducted ... Cancer Council of Victoria in Australia - looked into the ... waist measurement of more than 100 centimetres for men and ...
Cached Medicine News:Health News:New Technique Dissects Stem Cells' Picky Likes, Dislikes 2Health News:New Technique Dissects Stem Cells' Picky Likes, Dislikes 3Health News:Pain and Intensity Of Post-stroke Spasticity Decreased by Botox Treatment 2Health News:Denim, Not Cotton, Apt Wear for Summer 2
(Date:8/27/2014)... , Aug. 27, 2014 IRIDEX Corporation (NASDAQ: ... James H. Mackaness is scheduled to make an investor ... at 2:55 p.m. Eastern Time on Wednesday, September 3, in ... of the investor presentation will be available in the Investors ... About IRIDEX IRIDEX Corporation was founded ...
(Date:8/27/2014)... REDWOOD CITY, Calif. , Aug. 27, 2014 /PRNewswire/ ... specialty pharmaceutical company focused on the development and commercialization ... breakthrough pain, today announced that senior management will be ... and presenting at the Morgan Stanley Global Healthcare Conference. ... FBR Healthcare One on One Conference Date: Wednesday ...
(Date:8/26/2014)... Aug. 26, 2014 BioMed Realty Trust, Inc. ... of a new lease with GlycoMimetics, Inc. (NASDAQ: ... square feet at the Center for Life Science | ...  GlycoMimetics is a clinical-stage biotechnology company focused on the ... on an understanding of the role of carbohydrates in ...
Breaking Medicine Technology:AcelRx Pharmaceuticals to Participate in Two Upcoming Investor Events 2AcelRx Pharmaceuticals to Participate in Two Upcoming Investor Events 3BioMed Realty Signs New Lease With GlycoMimetics At Its Newly Redeveloped Center For Life Science | Shady Grove Campus In Rockville, Maryland 2BioMed Realty Signs New Lease With GlycoMimetics At Its Newly Redeveloped Center For Life Science | Shady Grove Campus In Rockville, Maryland 3
... (OTC Bulletin Board: NEPH ), a medical ... applications, infection control, and water purification, today announced that ... appointed as President and Chief Executive Officer.  In addition, ... board of directors of Nephros.  Effective upon Mr. Houghton,s ...
... 2012 QBC Diagnostics, a global manufacturer of ... that the company has been awarded a U.S. ... Scientific Equipment and Services. GSA,s Scientific ... agencies with scientific instruments for a wide variety ...
Cached Medicine Technology:Nephros Appoints John C. Houghton as President and Chief Executive Officer 2Nephros Appoints John C. Houghton as President and Chief Executive Officer 3Nephros Appoints John C. Houghton as President and Chief Executive Officer 4Nephros Appoints John C. Houghton as President and Chief Executive Officer 5QBC Diagnostics Awarded GSA Contract 2